351
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

CREST Syndrome in Systemic Sclerosis Patients – Is Dystrophic Calcinosis a Key Element to a Positive Diagnosis?

, ORCID Icon, , , , ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 3387-3394 | Published online: 09 Jun 2022

References

  • Boulman N, Slobodin G, Rozenbaum M, Rosner I. Calcinosis in rheumatic diseases. Semin Arthritis Rheum. 2005;34(6):805–812. doi:10.1016/j.semarthrit.2005.01.016
  • Morgan ND, Shah AA, Mayes MD, et al. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: analysis of the genome research in African American scleroderma patients clinical database. Medicine. 2017;96(51):e8980. doi:10.1097/MD.0000000000008980
  • Arana-Guajardo A, Villarreal-Alarcón M. CREST syndrome: clinical expression of the disease. J Clin Rheumatol. 2017;23(5):285. doi:10.1097/RHU.0000000000000491
  • Masi AT. Preliminary criteria for the classifications of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Arthritis Rheum. 1980;23(5):581–590. doi:10.1002/art.1780230510
  • van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747–1755. doi:10.1136/annrheumdis-2013-204424
  • Valenzuela A, Song P, Chung L. Calcinosis in scleroderma. Curr Opin Rheumatol. 2018;30(6):554–561. doi:10.1097/BOR.0000000000000539
  • Haustein UF. Systemic sclerosis-scleroderma. Dermatol Online J. 2002;8(1):3. doi:10.5070/D30VD8P0XW
  • Bobeica C, Niculet E, Halip AI, et al. Predictive value of immunological markers in systemic sclerosis. Exp Ther Med. 2021;22(3):1–5. doi:10.3892/etm.2021.10426
  • Meyer O. [CREST syndrome]. Ann Med Intern. 2002;153(3):183–188. French.
  • Winterbauer RH. Multiple telangiectasia, Raynaud’s phenomenon, sclerodactyly, and subcutaneous calcinosis: a syndrome mimicking hereditary hemorrhagic telangiectasia. Bull Johns Hopkins Hosp. 1964;114:361–383.
  • Ohira H, Watanabe H. Pathophysiology and recent findings of primary biliary cirrhosis complicated by systemic sclerosis. Hepatol Res. 2014;44(4):377–383. doi:10.1111/hepr.12285
  • Afifi N, Khalifa MM, Al Anany AA, Ali hassan HG. Cardiac calcium score in systemic sclerosis. Clin Rheumatol. 2022;41(1):105–114. doi:10.1007/s10067-021-05887-1
  • Magda S, Mincu R, Mihai C, Cinteza M, Vinereanu D. Atherosclerosis in systemic sclerosis: a modern controversy. Maedica. 2015;10(3):248–256.
  • Takahashi M, Nagata R, Ozaki A, Kaneko S, Saiki H, Matsumoto S. A case of anti-AQP4 antibody-positive recurrent myelitis overlapped with autoimmune disorders including incomplete CREST syndrome revealed multiple discontinuous cord lesions. Rinsho Shinkeigaku. 2009;49(2–3):115–118. doi:10.5692/clinicalneurol.49.115
  • Tatu AL, Ionescu MA. Multiple autoimmune syndrome type 3-thyroiditis, vitiligo and alopecia areata. Acta Endocrinol. 2017;13(1):124–125. doi:10.4183/aeb.2017.124
  • Brănișteanu DE, Pintilie A, Dimitriu A, et al. Clinical, laboratory and therapeutic profile of lichen planus. Rev Med Chir Soc Med Nat Iasi. 2017;121:25–32.
  • Tatu AL, Nwabudike LC The treatment options of male genital lichen sclerosus et atrophicus. Short Title for a Running Head: treatments of genital lichen sclerosus. Proceedings of the 14th national congress of Urogynecology and the national conference of the Romanian Association for the Study of Pain, September 07–09, 2017. Eforie, Romania; 2017:262–264.
  • Imura-Kumada S, Hasegawa M, Matsushita T, et al. High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis. Mod Rheumatol. 2012;22(6):892–898. doi:10.3109/s10165-012-0607-z
  • Horino T, Ichii O. Distal phalanx osteolysis and subcutaneous calcinosis in CREST syndrome. J Clin Rheumatol. 2021;27(1):e22. doi:10.1097/RHU.0000000000001210
  • Barsotti S, Orlandi M, Codullo V, et al. One year in review 2019: systemic sclerosis. Clin Exp Rheumatol. 2019;37Suppl 119(4):3–14.
  • Allanore Y. [Pathophysiology of systemic sclerosis]. Med Sci. 2016;32(2):183–191. French. doi:10.1051/medsci/20163202012
  • Niculet E, Chioncel V, Elisei AM, et al. Multifactorial expression of IL-6 with update on COVID-19 and the therapeutic strategies of its blockade (Review). Exp Ther Med. 2021;21(3):263. doi:10.3892/etm.2021.9693
  • Santiago T, Santiago M, Ruaro B, et al. Ultrasonography for the assessment of skin in systemic sclerosis: a systematic review. Arthritis Care Res. 2019;71(4):563–574. doi:10.1002/acr.23597
  • Ruaro B, Soldano S, Smith V, et al. Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study. Rheumatol. 2019;39(8):1369–1376.
  • Masi AT, Medsger TA Jr. Progress in the evolution of systemic sclerosis classification criteria and recommendation for additional comparative specificity studies. J Rheumatol. 2015;42(1):8–10. doi:10.3899/jrheum.141020
  • Jacobsen S, Halberg P, Ullman S, et al. Clinical features and antinuclear serum in 230 Danish patients with systemic sclerosis. Br J Rheumatol. 1998;37(1):39–45. doi:10.1093/rheumatology/37.1.39
  • Asano Y. Systemic Sclerosis. J Dermatol. 2018;45(2):128–138. doi:10.1111/1346-8138.14153
  • Johnson SR, van den Hoogen F, Devakandan K, Matucci-Cerinic M, Pope JE. Systemic sclerosis: to subset or not to subset, that is the question. Eur J Rheumatol. 2020;7(Suppl 3):S222–S227. doi:10.5152/eurjrheum.2020.19116
  • Steen VD. The many faces of scleroderma. Rheum Dis Clin North Am. 2008;34(1):1–15. doi:10.1016/j.rdc.2007.12.001
  • Bienvenu B. Treatment of subcutaneous calcinosis in systemic disorders. Rev Med Intern. 2014;35(7):444–452. doi:10.1016/j.revmed.2014.04.018
  • Dubos M, Ly K, Martel C, Fauchais AL. Is rituximab an effective treatment of refractory calcinosis? BMJ Case Rep. 2016;bcr2015213179. doi:10.1136/bcr-2015-213179
  • Gordon CM, Cleveland RH, Baltrusaitis K, et al. Extraskeletal calcifications in Hutchinson-Gilford Progeria syndrome. Bone. 2019;125:103–111. doi:10.1016/j.bone.2019.05.008
  • Nigwekar S, Bhan I, Turchin A, et al. Statin use and calcific uremic arteriolopathy: a matched case-control study. Am J Nephrol. 2013;37(4):325–332. doi:10.1159/000348806
  • Nwabudike LC, Elisei AM, Buzia OD, Miulescu M, Tatu AL. Statins. A review on structural perspectives, adverse reactions and relations with non-melanoma skin cancer. Rev Chim. 2018;69(9):2557–2562. doi:10.37358/RC.18.9.6575
  • Guo H, Li Q, Chou DW, Uitto J. Atorvastatin counteracts aberrant soft tissue mineralization in a mouse model of pseudoxanthoma elasticum (Abcc6⁻/⁻). J Mol Med (Berl). 2013;91(10):1177–1184. doi:10.1007/s00109-013-1066-5
  • Nwabudike LC, Tatu AL. Magistral prescription with silver nitrate and Peru balsam in difficult-to-heal diabetic foot ulcers. Am J Ther. 2018;25(6):e679–e680. (). doi:10.1097/MJT.0000000000000622
  • Draganescu M, Baroiu L, Iancu A, et al. Perspectives on skin disorder diagnosis among people living with HIV in southeastern Romania. Exp Ther Med. 2021;21(1):97. doi:10.3892/etm.2020.9529
  • LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–205.
  • Adigun R, Goyal A, Bansal P, Hariz A. Systemic Sclerosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; January, 2022 [ Updated July 3, 2021]. Available fromhttps://www.ncbi.nlm.nih.gov/books/NBK430875/. Accessed February 1, 2022.
  • Nishikawa T, Masuno K, Mori M, Tajime Y, Kakudo K, Tanaka A. Calcification at the interface between titanium implants and bone: observation with confocal laser scanning microscopy. J Oral Implantol. 2006;32(5):211–217. doi:10.1563/799.1